GO
Loading...

Allergan CEO: FDA Voted In Favor of Voluma

Thursday, 2 May 2013 | 6:15 PM ET

Allergan reported positive earnings on Wednesday, but the stock tumbled after. Its CEO David Pyott discusses earnings, drug delays and the future of the company.